Development and validation of a nomogram to evaluate the therapeutic effects of second-line axitinib in patients with metastatic renal cell carcinoma

Overview of attention for article published in Frontiers in oncology, February 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 24,271 followers.

Development and validation of a nomogram to evaluate the therapeutic effects of second-line axitinib in patients with metastatic renal cell carcinoma https://t.co/DVdIi7R3Tv https://t.co/vDnDgvE1AW

19 Feb 2023

Reply Repost Favourite

New research: Development and validation of a nomogram to evaluate the therapeutic effects of second-line axitinib in patients with metastatic renal cell carcinoma: The unpredictable biological behavior and tumor heterogeneity of metastatic… https://t.co/c

16 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.